low - Cancer treatment demand is non-discretionary and largely insulated from economic cycles. However, unemployment affects commercial insurance enrollment, and recessions can shift patients toward government programs. Medicare Advantage penetration (the primary payer channel) has grown consistently regardless of economic conditions, providing stable demand backdrop.

Rising rates negatively impact TOI through multiple channels: higher cost of capital for growth investments and clinic expansion, pressure on valuation multiples for unprofitable growth companies, and potential strain on working capital financing. The company's negative cash flow makes it dependent on capital markets access. Additionally, rising rates can pressure Medicare Advantage plan economics, potentially leading to tighter provider reimbursement negotiations.

growth/speculative - Attracts investors betting on value-based care secular trend and potential for operational turnaround as clinics mature. High-risk profile given negative profitability, cash burn, and execution uncertainty. Recent 177% one-year return followed by 34% six-month decline indicates momentum-driven trading and high retail participation. Not suitable for value or income investors given negative earnings and no dividend.